Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.

Autor: MONT, MICHAEL A., CARRINO, JOHN A., NEMETH, MARY ANNE, BURR, AIMEE, YAMABE, TAKAHARU, VIKTRUP, LARS, BROWN, MARK T., WEST, CHRISTINE R., VERBURG, KENNETH M.
Zdroj: Surgical Technology International; Jun2021, Vol. 38, p1-11, 11p
Databáze: Complementary Index